← Eichor
Study identifier: NCT07501078 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation

Condition: Ulcerative Colitis · Ileal Pouch  ·  Sponsor: Muhammad N Aslam, MD

PhasePhase 2
Planned participants52
Who can joinAll sexes, 5 Years to 80 Years
Healthy volunteersNo

About this study

Ulcerative colitis (UC) is a disease that causes long-term inflammation in the digestive tract, and many people with this condition require surgery to remove the colon and create a new J-pouch for stool. Some patients develop a problem called pouchitis, where this pouch becomes inflamed. Current treatments are limited, and there are no known ways to prevent pouchitis from starting. This study is being done to find out if a natural mineral supplement called Aquamin® can help reduce inflammation and protect the gut lining in people with a J-pouch, and may reduce the risk of pouchitis. By understanding whether Aquamin® is safe and helpful, the study team hopes to find a new and better way to prevent inflammation and improve the long-term health of people with UC.

This description comes directly from the study's public registry record.

Talk to the study team

Lauren Manning  ·  734-615-7236  ·  lbadish@med.umich.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of MichiganAnn Arbor, Michigan, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07501078